Trade Mark Journal No.2026/023 5 June 2026
UK00004389009 18 May 2026 (1,5,42)
GRAMICS BIO
- Class 1
- Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use; synthetic DNA or RNA or non-viral vectors for scientific, diagnostic or research use, other than for medical purposes.
- Class 5
- Pharmaceutical and medical preparations for therapeutic purposes; biological preparations for medical use in cell and gene therapies; pharmaceutical and biopharmaceutical preparations for medical use; reagents for use in medical genetic testing; medical preparations containing therapeutic DNA, RNA, non-viral vectors, proteins, polypeptides, or antibodies; synthetic DNA for pharmaceutical and medical use; preparations for genetically modifying human or animal cells for medical purposes; biological, chemical and biochemical reagents for medical use; biologicals and small chemical entities, namely DNA, RNA, non-viral vectors, proteins, polypeptides, antibodies for therapeutic purposes; cells for medical or clinical use; vaccines.
- Class 42
- Scientific and industrial research and analysis in the field of life sciences; scientific research services in the fields of synthetic DNA or RNA and non-viral vectors; pharmaceutical and biopharmaceutical drug development services; biological research; genomics research; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; pharmaceutical and biopharmaceutical research services, namely chemical and biological drug discovery services; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; diagnostic services; providing access to a proprietary technology platform containing small molecules, including synthetic DNA or RNA and non-viral vectors; medical research laboratory services; gene-editing services; providing a website featuring medical information and medical research; clinical trials; scientific and medical research and development in the field of gene therapy; software as a service (saas) relating to the design and manufacture of synthetic DNA, RNA and non-viral vectors; consultancy and advisory services related to research and development in the fields of medicine, vaccines and gene therapy.
GRAMICS BIO LTD
Representative: Stratagem Intellectual Property Management Limited